RABIES IMMUNOGLOBULINS. Dr.P.SANGRAM, MBBS, MD; MRC PATH (LONDON). Treatment of Rabies. WHO Recommendations ( based on category of dog bites) :. Treatment of Rabies. WHO Recommendations ( based on category of dog bites) :. WHO RECOMMENDS FOR ALL CATEGORY III EXPOSURES. Indication.
Related searches for RABIES IMMUNOGLOBULINS
Dr.P.SANGRAM, MBBS, MD; MRC PATH (LONDON)
Single or multiple transdermal bites or scratches
Contamination of mucous membrane with saliva (licks)
Rabies takes 20000 lives every year.
More than 70% victims are of category-III bites
Awareness of RIG is still poor
Only 6% victims gets complete treatment
20 Units per kg of body weight
40 Units per kg of body weight
Duration of Protective Effect:
Short: Rabies immunoglobulin has a half-life of approximately 21 days.
Cross sensitivity and/or related problems:
Patients sensitive to other human immune globulin products may be sensitive to Rabies Immunoglobulin also.
1) Mild Local Reaction: Anti histamines
2) Systemic reaction EPINEPHRINE 1:1000 (Aqueous) – 0.01ml / Kg per dose repeated every 10 – 20 minutes.
Infants – 0.05ml – 1ml
Children – 0.1 - 0.3 ml
Adolescents – 0.3 – 0.5 ml
3) SEVERE CASES:
HYDROCORTISONE : I.V 100 – 200 Mg / Kg
Provide Complete Treatment and
Protection against deadly Rabies
with ARV (Abhayrab) and RIG
(Abhay RIG) and save lives !!
Biotechnology in healthcare made affordable and accessible
Established by National Dairy Development Board
White revolution and operation flood
Cooperative movement in India
India-largest producer of Milk and milk products in the World
Division of Indian Immunologicals Limited :-
Experience and expertise of two decades in vaccine production
India’s first tissue culture rabies vaccine for veterinary use
Asia’s largest and World’s second largest manufacturers of veterinary vaccines
State-of-the-art manufacturing facilities-WHO and ISO-9001 approved
An ISO-9001 company
World class manufacturing facilities at Ooty
ISO-9001 and WHO GMP approved
India’s first and most affordable PVRV
World’s second manufacturing facility of PVRV